• Home
  • Search
  • Statistical methodology for highly variable compounds: A novel design approach for the ofatumumab Phase 2 bioequivalence study.
  • Cite Icon3
  • https://doi.org/10.1002/pst.2233Copy DOI Icon

Statistical methodology for highly variable compounds: A novel design approach for the ofatumumab Phase 2 bioequivalence study.

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

This article describes a novel mixed-scaling testing strategy, in combination with an adaptive parallel-groups bioequivalence trial, to test pharmacokinetic equivalence of two formulations of a drug with highly variable pharmacokinetics. The methodology was applied to the Phase 2 APLIOS study in relapsing multiple sclerosis patients, where the bioequivalence of subcutaneous ofatumumab 20 mg administered via an autoinjector pen (test formulation) versus prefilled syringe (reference formulation) in the abdomen has been studied. Due to a high coefficient of variation (CV) of the relevant pharmacokinetic metrics (AUCtau and Cmax ) for the reference formulation (>30%), a reference-Scaled bioequivalence (RSABE) approach was applied but modified for a parallel-groups design. In the absence of regulatory guidance for applying RSABE in parallel-group designs, and in contrast to the available regulatory guidance for RSABE in cross-over trials, the suggested testing strategy uses the between-subject variability of the reference drug instead of the corresponding within-subject variability that would be available if a standard cross-over bioequivalence trial had been possible. Moreover, due to high uncertainty in the initial CV estimate for the sample size determination, a two-stage adaptive design was used, allowing for a sample size adjustment based on the pharmacokinetic variability observed at an interim analysis. The interim analysis timing was pre-specified based on simulations which included re-estimation of the final sample size at the end of the first stage to ensure sufficient power of the RSABE test at the end of the second stage. Using this approach, bioequivalence was shown between the test and reference formulations. The APLIOS trial is registered at ClinicalTrials.gov: NCT03560739.

Similar Papers
  • Research Article
  • Citations8

Pharmacokinetic Comparison of 2 Formulations of Anastrozole (1 mg) in Healthy Korean Male Volunteers: A Randomized, Single-Dose, 2-Period, 2-Sequence, Crossover Study

  • Jan 25, 2012
  • Clinical Therapeutics
  • Yook-Hwan Noh +11
  • Research Article
  • Citations11

Pharmacokinetic Comparison Study of a Combination Containing 500 mg of Naproxen and 20 mg of Esomeprazole: A Randomized, Single-dose, 2-way Crossover, Open-label Study in Healthy Korean Men

  • Dec 04, 2014
  • Clinical Therapeutics
  • Hyun-Gyu Choi +10
  • Research Article
  • Citations4

Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial

  • Feb 01, 2021
  • Biomedicine & Pharmacotherapy
  • Qiuying Li +3
  • Research Article
  • Citations7

Bioequivalence Study of Two Losartan Formulations Administered Orally in Healthy Male Volunteers

  • Dec 21, 2011
  • Arzneimittelforschung
  • Agnieszka Bienert +8
  • Research Article
  • Citations2

Bioequivalence Studies for 2 Different Strengths of Irbesartan/hydrochlorothiazide Combination in Healthy Volunteers: 300/25 mg and 300/12.5 mg Film-coated Tablets

  • Oct 08, 2013
  • Drug Research
  • M Cánovas +2
  • PDF
  • Research Article
  • Citations8

Bioequivalence of two tacrolimus 1-mg formulations under fasting conditions in healthy subjects: A randomized, two-period crossover trial

  • Dec 16, 2019
  • International Journal of Clinical Pharmacology and Therapeutics
  • Lalitendu Mohanty +2
  • Research Article
  • Citations17

Amlodipine bioequivalence achieved with a very sensitive liquid chromatography tandem mass spectrometric bioassay.

  • Dec 27, 2011
  • Arzneimittel-Forschung
  • Antonio Marzo +7
  • Research Article
  • Citations1

Bioequivalence study of cefepime intramuscular injection

  • Apr 01, 2014
  • Asian Biomedicine
  • Monchana Jullangkoon +2
  • Research Article
  • Citations6

Pharmacokinetics and Bioequivalence Evaluation of Two Brands of Ciprofloxacin 500 mg Tablets in Iranian Healthy Volunteers

  • Oct 09, 2012
  • Arzneimittelforschung
  • H Valizadeh +4
  • PDF
  • Research Article
  • Citations28

The Affect of Capmul, Labrafil and Transcutol on Progesterone 100 Mg Soft Capsules Bioavaialbility in Indian Healthy Adult Postmenopausal Female Subjects Under Fasting Conditions

  • Jan 01, 2015
  • Journal of Bioequivalence & Bioavailability
  • Rajeswara Rao P Someswara Rao K
  • Research Article
  • Citations9

Bioequivalence and Pharmacokinetic Evaluation Study of Acetaminophen vs. Acetaminophen Plus Caffeine Tablets in Healthy Mexican Volunteers

  • Oct 12, 2016
  • Drugs in R&D
  • Nora Angélica Núñez Guzmán +4
  • Research Article
  • Citations4

Pharmacokinetic and bioequivalence assessment of two formulations of tianeptine sodium in healthy male volunteers.

  • Sep 01, 2014
  • International journal of clinical pharmacology and therapeutics
  • Renhua Zheng +1
  • Research Article
  • Citations3

Pharmacokinetics and Bioequivalence Evaluation of Erlotinib Hydrochloride Tablets: Randomized, Open-Label, 2-Period Crossover Study in Healthy Chinese Subjects.

  • May 16, 2020
  • Clinical pharmacology in drug development
  • Lu Wang +9
  • Research Article
  • Citations2

Bioavailability study of two different formulations of azithromycin

  • Apr 01, 1996
  • Current Therapeutic Research
  • Luigi Ferrante +4
  • Research Article
  • Citations9

Pharmacokinetic Properties and Bioequivalence of 2 Formulations of Valsartan 160-mg Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Korean Male Volunteers

  • Feb 01, 2014
  • Clinical Therapeutics
  • Ji-Eon Kim +6
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.